TIFF Advisory Services’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-195,469
Closed -$565K 24
2026
Q1
$565K Sell
195,469
-100
-0.1% -$307 0.13% 25
2025
Q4
$696K Sell
195,569
-661,059
-77% -$2.45M 0.12% 19
2025
Q3
$2.99M Sell
856,628
-2,777,837
-76% -$9.52M 0.62% 18
2025
Q2
$7.45M Buy
3,634,465
+655,324
+22% +$1.64M 1.76% 10
2025
Q1
$3.4M Hold
2,979,141
0.81% 10
2024
Q4
$921K Buy
2,979,141
+346,256
+13% +$89.8K 0.3% 18
2024
Q3
$861K Buy
2,632,885
+1,214,200
+86% +$503K 0.29% 19
2024
Q2
$653K Buy
1,418,685
+995,280
+235% +$849K 0.23% 20
2024
Q1
$669K Hold
423,405
0.29% 16
2023
Q4
$864K Hold
423,405
0.41% 18
2023
Q3
$593K Buy
+423,405
New +$438K 0.49% 15

Other funds holding STLN

TIFF Advisory Services's STLN Position: Q2 2026 in Review

TIFF Advisory Services sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q2 2026, closing a stake of 195,469 shares — an estimated $565K sold.

TIFF Advisory Services first reported a position in STLN in Q3 2023 and held it in 11 quarters. The position peaked at $7.45M in Q2 2025. 29 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • TIFF Advisory Services reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q2 2026 after selling out during the quarter.
  • TIFF Advisory Services sold 195,469 Starling Oncology Institute, Inc. Common Stock shares in Q2 2026, an estimated $565K.
  • TIFF Advisory Services first reported a position in Starling Oncology Institute, Inc. Common Stock in Q3 2023 and held it in 11 quarters.
  • TIFF Advisory Services's Starling Oncology Institute, Inc. Common Stock position peaked at $7.45M in Q2 2025.
  • 29 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2026.

Based on TIFF Advisory Services's 13F filing for Q2 2026, filed 29 Jul 2026.